A single dose of the recombinant respiratory syncytial virus (RSV) vaccine demonstrates effectiveness against infections and associated hospitalizations in veterans aged 60 years or older during ...

Children aged 6 months to 12 years are the main spreaders of respiratory syncytial virus (RSV) infections within their households, based on data from more than 3000 individuals. Previous studies ...